Skip to main content

Table 7 Subgroup (10.1–15 mm) analysis of stone clearance time

From: Role of Tamsulosin with or without Deflazacort to facilitate stone clearance after ESWL: a single-center randomized controlled study

Groups

Number of patients in subgroup (10.1–15 mm)

Clearance time in days (mean ± SD)

Comparative group

Mean difference

P value

A

70

20.00 ± 11.09

B

− 5.000

0.466

   

C

− 12.000

0.034

B

70

25.00 ± 8.55

A

5.000

0.466

   

C

− 7.000

0.292

C

50

32.00 ± 13.98

A

12.000

0.034

   

B

7.000

0.292